Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Axitinib as Pre-Surgical Therapy in Patients With High Risk Prostate Cancer
NCT01385059Phase 2Completed
- Sponsor
- City of Hope
- Start
- Dec 2011
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of axitinib in prostate cancer (PCa), sponsored by City of Hope. Started Dec 2011; status: completed.
02
Drugs
axitinib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01385059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01385059.